Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.1062
Abstract: Osteoporosis is a common skeletal disorder, often leading to fragility fracture. Combination therapy with raloxifene, a selective estrogen receptor modulator, and cholecalciferol (vitamin D3) has been proposed to improve the overall efficacy and increase compliance…
read more here.
Keywords:
time;
raloxifene cholecalciferol;
drug;
interaction raloxifene ... See more keywords